Abstract
The Structural Vaccinology (SV) approach is the logical evolution of Reverse Vaccinology: a genome-based approach combined with structural biology, with the idea that protective determinants can be used to selectively engineer the antigens that can be re-designed and simplified for inclusion in vaccine combinations. The final objectives of the rational structure-based antigen optimization are the facilitation of industrial-scale production of the antigens combination, obtain a greater immunogenicity and a greater safety profile and finally expand the breadth of protection. Structural Vaccinology is particularly powerful in case of antigenic variation between closely related strains and species. Several examples are available in literature of how SV has already been applied successfully to several bacterial and viral projects. The examples of structure-based antigens optimization reviewed here describe different template procedures that can be followed to develop improved vaccines against other pathogens and potentially help resolve challenges in manufacturing or efficacy.
Keywords: Vaccines, X-ray crystallography, TEM Group B streptococcus, Meningococcus B, structure-based vaccines, Ehrlichia chaffeensis, OspA, alpha-hemolysin, HIV vaccines, influenza hemagglutinin.
Current Topics in Medicinal Chemistry
Title:Structural Vaccinology: A Three-dimensional View for Vaccine Development
Volume: 13 Issue: 20
Author(s): Ilaria Ferlenghi, Roberta Cozzi and Maria Scarselli
Affiliation:
Keywords: Vaccines, X-ray crystallography, TEM Group B streptococcus, Meningococcus B, structure-based vaccines, Ehrlichia chaffeensis, OspA, alpha-hemolysin, HIV vaccines, influenza hemagglutinin.
Abstract: The Structural Vaccinology (SV) approach is the logical evolution of Reverse Vaccinology: a genome-based approach combined with structural biology, with the idea that protective determinants can be used to selectively engineer the antigens that can be re-designed and simplified for inclusion in vaccine combinations. The final objectives of the rational structure-based antigen optimization are the facilitation of industrial-scale production of the antigens combination, obtain a greater immunogenicity and a greater safety profile and finally expand the breadth of protection. Structural Vaccinology is particularly powerful in case of antigenic variation between closely related strains and species. Several examples are available in literature of how SV has already been applied successfully to several bacterial and viral projects. The examples of structure-based antigens optimization reviewed here describe different template procedures that can be followed to develop improved vaccines against other pathogens and potentially help resolve challenges in manufacturing or efficacy.
Export Options
About this article
Cite this article as:
Ferlenghi Ilaria, Cozzi Roberta and Scarselli Maria, Structural Vaccinology: A Three-dimensional View for Vaccine Development, Current Topics in Medicinal Chemistry 2013; 13 (20) . https://dx.doi.org/10.2174/15680266113136660187
DOI https://dx.doi.org/10.2174/15680266113136660187 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neutrophil Activation Induced by Plant Lectins: Modulation of Inflammatory Processes
Inflammation & Allergy - Drug Targets (Discontinued) Caenorhabditis elegans-based Model Systems for Antifungal Drug Discovery
Current Pharmaceutical Design Antibodies: Can They Protect Against HIV Infection?
Current Drug Targets - Infectious Disorders Antibiotic Treatment in Native Valve Infective Endocarditis
Infectious Disorders - Drug Targets The Use of Proteomics to Study Infectious Diseases
Infectious Disorders - Drug Targets Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Sepsis Pathophysiology and Anesthetic Consideration
Cardiovascular & Hematological Disorders-Drug Targets Synthesis of New α-Amino Phosphonates Containing 3-Amino-4(3H) Quinazolinone Moiety as Anticancer and Antimicrobial Agents: DFT, NBO, and Vibrational Studies
Current Organic Synthesis Pharmacotherapy of Sickle Cell Disease in Children
Current Pharmaceutical Design Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application
Current Gene Therapy Rediscovering the Antibiotics of the Hive
Recent Patents on Anti-Infective Drug Discovery Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19
Mini-Reviews in Medicinal Chemistry Synthesis and Biological Activities of New Halophenols
Medicinal Chemistry What we have Learned from Animal Models of Mycoplasma pneumoniae Disease: Virulence Mechanisms and Host Responses
Current Pediatric Reviews Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) [177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Current Radiopharmaceuticals Crystal Structure and Interaction of Phycocyanin with β-Secretase: A Putative Therapy for Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Communicating Vaccine Safety to the Media and General Public
Current Drug Safety The Causative Organisms of Bacterial Meningitis and their Antimicrobial Resistance Profiles in Iranian Children in 2011-2016
Infectious Disorders - Drug Targets